Ipsen - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Ipsen. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Ipsen. The Group's principal activity is to develop and distribute pharmaceutical products. The Group develops innovative drugs used in therapeutic areas in oncology, endocrinology and neuromuscular disorders. Some of their products include Decapeptyl, Somatuline, NutropinAq, Autogel, Forlax, Tanakan, Testim and Dysport. The Group also offers products on primary care which includes the areas of gastroenterology, cardiovascular and cognitive disorders. The Group operates throughout the world, In 2008, the Group acquired Vernalis Pharmaceuticals and Tercica Inc.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report